FDA Inspection 1019488 — Central Iowa Health System

Central Iowa Health System — FEI 1970357

The FDA completed an inspection of Central Iowa Health System on June 28, 2017 in Des Moines, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 28, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Des Moines, IA (United States)